Daunorubicin Injection 20 Mg

Daunorubicin Injection 20 Mg Specification

Packaging Type
Vial with ampoule

Life Span
36 months

Brand Name
Daunotec

Indication
Acute myeloid leukemia, Acute lymphocytic leukemia

Pacakaging (Quantity Per Box)
1 vial + 1 ampoule per box

Dosage Form
Injection

Salt Composition
Daunorubicin Hydrochloride

Drug Type

Ingredients
Daunorubicin Hydrochloride

Physical Form
Injection

Function
Antineoplastic agent

Recommended For
Leukemia, Cancer therapy

Dosage
As directed by physician

Dosage Guidelines
Intravenous use only

Suitable For
Adults and children

Quantity
1 vial + 1 ampoule

Storage Instructions
Store below 25C, protect from light

Marketed In
Asia, Africa

Pack Type
Vial

Strength
20 mg

Reconstitution Required
Yes

Expiry Date
See pack

Usages
Hospital, Clinical use

Pack Size
1 Vial 20 mg + 1 Ampoule 10 mg

Appearance
Red colored solution

Prescription Required
Yes

Administration Route
IV infusion

Daunorubicin Injection 20 Mg Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
5000 Vials Per Month

Delivery Time
2-10 Days

About Daunorubicin Injection 20 Mg

Daunorubicin Injection 20 Mg, branded as Daunotec, is a must-have in the realm of antineoplastic therapy. With its ace formulation of 20 mg Daunorubicin Hydrochloride per vial paired with a 10 mg ampoule, this popular red colored solution embodies opulence in hospital and clinical cancer care. Renowned among professionals across Asia and Africa, this product is specifically recommended for adults and children battling acute myeloid and lymphocytic leukemia. Its enviable performance and reliable supply make it a standout choice for prescription-based cancer therapy under expert supervision.

Superior Material Feature and Clinical Usage

Daunorubicin Injection 20 Mg is formulated as a red colored solution, offering remarkable purity and consistency. Its application media is tailored for intravenous infusion, making it suitable exclusively for professional hospital and clinical use. This cytotoxic chemotherapy agent is expertly crafted to deliver optimal results in the treatment of acute myeloid and lymphocytic leukemia, reflecting a commitment to efficacy and patient care in demanding medical settings.

Sample Policy, Export Markets, and Supply Dynamics

Our sample policy ensures minimal investment, with list prices provided upon request. Samples can be shipped globally based on the proposal amount and specific client requirements. The main export markets include Asia and Africa, supported by robust supply ability to meet growing demand. Each box contains 1 vial and 1 ampoule, ensuring reliable distribution for exporters, suppliers, traders, and wholesalers seeking trusted oncology solutions.

FAQ's of Daunorubicin Injection 20 Mg:

Q: How should Daunorubicin Injection 20 Mg be administered?

A: Daunorubicin Injection 20 Mg must be administered exclusively via intravenous infusion by a qualified healthcare professional, following the physician's dosage guidelines and reconstitution requirements.

Q: What is the primary use of Daunorubicin Injection 20 Mg?

A: This injection is primarily used as a cytotoxic chemotherapy agent for treating acute myeloid leukemia and acute lymphocytic leukemia in both adults and children.

Q: When does Daunorubicin Injection 20 Mg expire?

A: The expiry date is clearly mentioned on each pack. The injection generally has a lifespan of 36 months from the date of manufacturing.

Q: Where is Daunorubicin Injection 20 Mg marketed and supplied?

A: Daunorubicin Injection 20 Mg is actively marketed in countries across Asia and Africa and is supplied by exporters, suppliers, traders, and wholesalers from India.